On February 26, 2024, Huadao Biopharma (Shanghai) Co., Ltd. closed the transaction. The transaction inluded participation from returning investors Sinowisdom Capital, Chongqing Kexing Equity Investment Management Co., Ltd. and new investor Yin Ming.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.19 CNY | +1.51% | -0.27% | +23.00% |
26/04 | Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2023 | CI |
25/04 | Boai NKY Medical Holdings Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.00% | 930M | |
+16.91% | 66.18B | |
+1.64% | 49.24B | |
+16.70% | 41.72B | |
+22.58% | 26.16B | |
+12.92% | 19.75B | |
+2.79% | 17.5B | |
-23.54% | 15.63B | |
-6.24% | 15.46B | |
+2.52% | 15.43B |
- Stock Market
- Equities
- 300109 Stock
- News Boai NKY Medical Holdings Ltd.
- Huadao Biopharma Co., Ltd. announced that it has received CNY 20 million in funding from Boai NKY Medical Holdings Ltd., Chongqing Kexing Equity Investment Management Co., Ltd., Sinowisdom Capital and another investor